Ngenla 60 mg/1.2mL

Somatrogon-Ghla, the active ingredient in Ngenla, is a growth hormone analog presented as a 60 mg/1.2 mL injection, solution for subcutaneous use. It is used to treat growth hormone deficiency in pediatric patients aged 3 years and older. GNH USA supplies Ngenla as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Ngenla is a prescription medication designed to address growth hormone deficiency, helping children achieve a more typical height and weight for their age. It is administered via subcutaneous injection and is available in two strengths to accommodate different dosing needs.

Ngenla is used to treat growth hormone deficiency (GHD) in pediatric patients. This condition occurs when the pituitary gland does not produce enough growth hormone, leading to inadequate growth and development.

- Growth Hormone Deficiency in Children: Promotes linear growth and helps children reach a height and weight more typical for their age. - Inadequate Growth Hormone Production: Addresses the underlying cause of GHD, which can be congenital or acquired due to conditions like pituitary gland tumors or autoimmune diseases. - Symptoms of GHD: Helps alleviate symptoms such as slow development of nails, teeth, facial bones, long bones, and general growth.

Ngenla may cause side effects, although not everyone experiences them. Common Side Effects: - Injection site reactions: Redness, swelling, or pain at the injection site. - Headache: Mild to moderate headaches. - Joint pain: Discomfort in the joints. - Muscle pain: Aching or discomfort in the muscles.

Serious or Rare Side Effects: - Hypothyroidism: Reduced thyroid function, which may require additional treatment. - Slipped capital femoral epiphysis: A condition affecting the hip joint, which may require medical intervention. - Increased pressure in the skull: Symptoms may include headaches, vision problems, or nausea. - Allergic reactions: Severe allergic reactions, including rash, itching, or difficulty breathing.

Before using Ngenla, it is important to consider certain precautions. Inform your healthcare provider about all medical conditions, especially if your child has cancer, tumors, or certain types of eye problems caused by diabetes. Regular monitoring of growth and development is essential during treatment.

- Cancer or Tumors: Inform your healthcare provider if your child has a history of cancer or tumors. - Eye Problems: Notify your healthcare provider if your child has certain types of eye problems caused by diabetes. - Regular Monitoring: Regularly monitor your child's growth and development during treatment. - Injection Site Rotation: Rotate the injection site each week to prevent injection site reactions. - Storage: Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Ngenla may interact with other medications, so it is important to inform your healthcare provider about all medications your child is taking. Major Interactions (Avoid): - Corticosteroids: May reduce the effectiveness of Ngenla. - Insulin or Oral Hypoglycemic Agents: May require dose adjustments due to changes in blood sugar levels.

Moderate Interactions (Monitor Closely): - Thyroid Hormones: May require dose adjustments due to changes in thyroid function. - Antiepileptic Drugs: May affect the metabolism of Ngenla. - Immunosuppressants: May require dose adjustments due to changes in immune function.